Productivity and medical costs of diabetes in a large employer population

Diabetes Care

Volumn 25, Issue 1, 2002, Pages 23-29

  Ramsey, Scott ^a   Summers, Kent H ^b   Leong, Stephanie A ^c   Birnbaum, Howard G ^c   Kemner, Jason E ^b   Greenberg, Paul ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Analysis Group/Economics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMORBIDITY; COST BENEFIT ANALYSIS; DATA ANALYSIS; DATA BASE; DIABETES MELLITUS; DISABILITY; DISEASE ASSOCIATION; ECONOMIC ASPECT; EMPLOYEE; EMPLOYER; HEALTH CARE COST; HEALTH INSURANCE; POPULATION; POPULATION RESEARCH; PREVALENCE; PRODUCTIVITY; WORK; ADOLESCENT; ADULT; AGE DISTRIBUTION; COMPARATIVE STUDY; COST; ECONOMICS; EMPLOYMENT; FACTUAL DATABASE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COMORBIDITY; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; DIABETES MELLITUS; EFFICIENCY; EMPLOYMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; UNITED STATES;

EID: 0036364589     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.1.23     Document Type: Article

References (32)

1. Roman SH, Harris MI: Management of diabetes mellitus from a public health perspective. Endocrinol Metab Clin North Am 26:443-474, 1997
2. O'Brien JA, Shomphe LA, Kavanagh PL, Raggio GSCD, Caro JJ: Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 21: 1122-1128, 1998
3. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrdholt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-241, 1998
4. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Diabetes Public Health Resource, Statistics: Diabetes surveillance report, chapter 3: mortality, Table 3.2 [article online], 1999. Available from http://www.cdc.gov/diabetes/statistics/ survl99/chap3/table2.htm. Accessed 20 September, 2001.
5. Brown JB, Nichols GA, Glauber HS, Bakst AW: Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 22:1116-1124, 1999
6. American Diabetes Association: Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21:296-309, 1998
7. Brown JB, Pedula KL, Bakst AW: The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 159:1873-1880, 1999
8. Hodgson TA, Cohen AJ: Medical care expenditures for diabetes, its chronic complications and its comorbidities. Prev Med 29:173-186, 1999
9. Selby JV, Ray GT, Zhang D, Colby CJ: Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20:1396-1402, 1997
10. Ramsey SD, Newton K, Blough D, McCullough DK, Sandhu N, Wagner EH: Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics 16: 285-295, 1999
11. Songer TJ: Disability in diabetes. In Diabetes in America. 2nd ed. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995, pp. 259-282 (NIH publ. no. 95-1468)
12. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW: The role of health risk factors and disease on worker productivity. J Occup Environ Med 41:863-877, 1999
13. Persson U: The indirect costs of morbidity in type II diabetic patients. Pharmacoeconomics 8 (Suppl. 1):28-32, 1995
14. Valdmanis V, Smith DW, Page MR: Productivity and economic burden associated with diabetes. Am J of Public Health 91:129-130, 2001
15. Mayfield JA, Deb P, Whitecotton L: Work disability and diabetes. Diabetes Care 22:1105-1109, 1999
16. Ng YC, Jacobs P, Johnson JA: Productivity losses associated with diabetes in the US. Diabetes Care 24:257-261, 2001
17. SAS User's Guide: SAS/STAT User's Guide. Version 8. Cary, NC, SAS Inst., 1999
18. Farquhar I, Sorkin A, Summers KH, Weir E: Concomitant illnesses in patients with diabetes: mortality, benefits of newer treatments and individual and societal costs. Research in Human Capital and Development, Investing in Health: The Social and Economic Benefits of Health Care Innovation. Vol. 14. Farquhar I, Sorkin A, Summers K, Eds. Kidlington, U.K., Elsevier Science, 2001, p. 1-22
19. Smith TL, Melfi CA, Kesterson JA, Sandmann BJ, Kotsanos JG: Direct medical charges associated with myocardial infarction in patients with and without diabetes. Med Care 37 (4 Suppl.):AS4-AS11, 1999
20. CDC Diabetes in Managed Care Work Group: Diabetes mellitus in managed care: complications and resource utilization. Am J Managed Care 7:501-508, 2001
21. Birnbaum HG, Cremieux PY, Greenberg PE, LeLorier J, Ostrander J, Venditti L: Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 16:1-8, 1999
22. Luce BR, Manning WG, Siegel JE, Lipscomb J: Estimating costs in cost-effectiveness analysis. In Cost-Effectiveness in Health and Medicine. New York, Oxford University Press, 1996, p. 176-213
23. Drummond MF, O'Brien B, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. Oxford, U.K., Oxford University Press, 1994, p. 21,48,78,79
24. National Institute of Diabetes and Digestive and Kidney Disease: Diabetes statistics [article online], 1999. Available from: http://www.niddk.nih.gov/ health/diabetes/pubs/dmstats/dmstats.htm. Accessed May 2001
25. Clark MJ Jr, Sterrett JJ, Carson DS: Diabetes guidelines: a summary and comparison of the recommendations of the American Diabetes Association, Veterans Health Administration, and American Association of Clinical Endocrinologists. Clin Ther. 22:899-910 [discussion 898], 2000
26. Miller CD, Phillips LS, Tate MK, Porwoll JM, Rossman SD, Cronmiller N, Gebhart SSP: Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care 23:444-448, 2000
27. Klesges RC, Klem ML, Hanson CL, Eck LH, Ernst J, O'Laughlin D, Garrott A, Rife R: The effects of applicant's health status and qualifications on simulated hiring decisions. Int J Obesity 14:527-535, 1990
28. Field RI: The frontiers of genetics and the transformation of medicine and business. Research in Human Capital and Development 14:155-196, 2001
29. Diabetes Control and Complications Trial Research Group: Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA 276:1409-1415, 1996
30. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
31. Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. JAMA 280: 1490-1496, 1998
32. Rizzo JA, Abbott TA 3rd, Pashko S: Labour productivity effects of prescribed medicines for chronically ill workers. Health Econ 5:249-265, 1996